ArticleNPJ vaccines2018
Production, quality control, stability, and potency of cGMP-produced
Open access · goldAbstract read
In one paragraph
Article in NPJ vaccines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.
0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 80 citations in OpenAlex.
- Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies.Cell reports. Medicine · 2021Trial
- Protein/AS01Cell reports. Medicine · 2021Trial
- Metabolic Footprint of Drosophila S2 Cells: Findings During the Production of a Recombinant Rabies Virus Glycoprotein.Biotechnology journal · 2026Article
- Efficient Construction of Recombinant CHO Cells for Stable Expression of Therapeutic Proteins Based on New Hotspot 'LOC'.Molecular biotechnology · 2026Article
- Recent Advances, Bottlenecks, and Future Directions inVaccines · 2026Review
- From Lab to Clinic and Farm: LeveragingBiology · 2025Review
- PfRH5 vaccine; from the bench to the vial.NPJ vaccines · 2025Review
- Antibody correlates of risk of clinical malaria in an area of low and unstable malaria transmission in western Kenya.Malaria journal · 2025Article
- Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.Immunological reviews · 2025Review
- Rational structure-guided design of a blood stage malaria vaccine immunogen presenting a single epitope from PfRH5.EMBO molecular medicine · 2024Article
- Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial.The Lancet. Infectious diseases · 2024Article
- Innate immune cell activation by adjuvant AS01 in human lymph node explants is age independent.The Journal of clinical investigation · 2024Article
- Article
- Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.Cell reports. Medicine · 2024Article
- Vaccine adjuvants for infectious disease in the clinic.Bioengineering & translational medicine · 2024Review
- Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.Nature communications · 2024Article
- A Microsphere Immunoassay for the Quantitative Detection of Antigens in Cell Culture Supernatant.Methods in molecular biology (Clifton, N.J.) · 2024Article
- Article
- The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals.Malaria journal · 2023Article
- Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine.JCI insight · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors at 3 institutions in 3 countries.
Jing Jin1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Richard D Tarrant2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Emma J Bolam2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Philip Angell-Manning2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Max SoegaardExpreS²ion Biotechnologies, SCION-DTU Science Park, Agern Allé, 12970 Hørsholm, Denmark.
David J Pattinson1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Pawan Dulal1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Sarah E Silk1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Jennifer M Marshall1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Rebecca A Dabbs1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Fay L Nugent1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Jordan R Barrett1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Kathryn A Hjerrild1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Lars PoulsenExpreS²ion Biotechnologies, SCION-DTU Science Park, Agern Allé, 12970 Hørsholm, Denmark.
Thomas JørgensenExpreS²ion Biotechnologies, SCION-DTU Science Park, Agern Allé, 12970 Hørsholm, Denmark.ORCID 0000-0002-4868-8735
Tanja Brenner2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Ioana N Baleanu2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Helena M Parracho2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Abdessamad Tahiri-Alaoui2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Gary Whale2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Sarah Moyle2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Ruth O Payne1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Angela M Minassian1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Matthew K Higgins4Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU UK.
Frank J Detmers5Thermo Fisher Scientific, J.H. Oortweg 21, 2333 CH Leiden, Netherlands.
Alison M Lawrie1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Alexander D Douglas1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Robert Smith2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Willem A de JonghExpreS²ion Biotechnologies, SCION-DTU Science Park, Agern Allé, 12970 Hørsholm, Denmark.
Eleanor Berrie2Clinical BioManufacturing Facility, University of Oxford, Oxford, OX3 7JT UK.
Rebecca Ashfield1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.
Simon J Draper1The Jenner Institute, University of Oxford, Old Road Campus Research Building, Oxford, OX3 7DQ UK.ORCID 0000-0002-9415-1357
University of Oxford · GBExpreS2ion Biotechnologies (Denmark) · DKThermo Fisher Scientific (Netherlands) · NL
Funding
Medical Research Council MR/K025554/1Wellcome Trust 201477/Z/16/Z
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.